Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Strati

Showing results (41-50 of 139) with videos related to

Pageof 14
Sort By:
Blood|July 31, 2013
Clinical characteristics and outcomes of therapy-related chronic myelomonocytic leukemiaKoichi Takahashi, Naveen Pemmaraju, Paolo Strati, et al.
British Journal of Haematology|June 6, 2017
Relationship between co-morbidities at diagnosis, survival and ultimate cause of death in patients with chronic lymphocytic leukaemia (CLL): a prospective cohort studyPaolo Strati, Sameer A Parikh, Kari G Chaffee, et al.
Cancers|July 2, 2021
Early Survival Prediction Framework in CD19-Specific CAR-T Cell Immunotherapy Using a Quantitative Systems Pharmacology ModelAnna Mueller-Schoell, Nahum Puebla-Osorio, Robin Michelet, et al.
American Journal of Hematology|November 2, 2012
FLT3 mutations in myelodysplastic syndrome and chronic myelomonocytic leukemiaNaval Daver, Paolo Strati, Elias Jabbour, et al.
British Journal of Haematology|July 21, 2022
A phase 2, multicentre, open-label trial (ACE-LY-003) of acalabrutinib in patients with relapsed or refractory marginal zone lymphomaPaolo Strati, Morton Coleman, Rebecca Champion, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 2, 2021
Human herpesvirus 6 myelitis after chimeric antigen receptor T-cell therapyGuy Handley, Fareed Khawaja, Divya S Kondapi, et al.
Oncotarget|November 19, 2016
A randomized phase II trial comparing chemoimmunotherapy with or without bevacizumab in previously untreated patients with chronic lymphocytic leukemiaNeil E Kay, Paolo Strati, Betsy R LaPlant, et al.
Blood|June 27, 2013
Lenalidomide induces long-lasting responses in elderly patients with chronic lymphocytic leukemiaPaolo Strati, Michael J Keating, William G Wierda, et al.
Blood|April 8, 2014
Eradication of bone marrow minimal residual disease may prompt early treatment discontinuation in CLLPaolo Strati, Michael J Keating, Susan M O'Brien, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 7, 2025
Perspectives on Current Challenges and Emerging Approaches for Lymphoma Management From the First Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma ConferenceAlexey V Danilov, Craig Sauter, Tycel Phillips, et al.
Pageof 14

Showing results (41-50 of 139) with videos related to

Sort By:
Pageof 14
Blood|July 31, 2013
Clinical characteristics and outcomes of therapy-related chronic myelomonocytic leukemiaKoichi Takahashi, Naveen Pemmaraju, Paolo Strati, et al.
British Journal of Haematology|June 6, 2017
Relationship between co-morbidities at diagnosis, survival and ultimate cause of death in patients with chronic lymphocytic leukaemia (CLL): a prospective cohort studyPaolo Strati, Sameer A Parikh, Kari G Chaffee, et al.
Cancers|July 2, 2021
Early Survival Prediction Framework in CD19-Specific CAR-T Cell Immunotherapy Using a Quantitative Systems Pharmacology ModelAnna Mueller-Schoell, Nahum Puebla-Osorio, Robin Michelet, et al.
American Journal of Hematology|November 2, 2012
FLT3 mutations in myelodysplastic syndrome and chronic myelomonocytic leukemiaNaval Daver, Paolo Strati, Elias Jabbour, et al.
British Journal of Haematology|July 21, 2022
A phase 2, multicentre, open-label trial (ACE-LY-003) of acalabrutinib in patients with relapsed or refractory marginal zone lymphomaPaolo Strati, Morton Coleman, Rebecca Champion, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 2, 2021
Human herpesvirus 6 myelitis after chimeric antigen receptor T-cell therapyGuy Handley, Fareed Khawaja, Divya S Kondapi, et al.
Oncotarget|November 19, 2016
A randomized phase II trial comparing chemoimmunotherapy with or without bevacizumab in previously untreated patients with chronic lymphocytic leukemiaNeil E Kay, Paolo Strati, Betsy R LaPlant, et al.
Blood|June 27, 2013
Lenalidomide induces long-lasting responses in elderly patients with chronic lymphocytic leukemiaPaolo Strati, Michael J Keating, William G Wierda, et al.
Blood|April 8, 2014
Eradication of bone marrow minimal residual disease may prompt early treatment discontinuation in CLLPaolo Strati, Michael J Keating, Susan M O'Brien, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 7, 2025
Perspectives on Current Challenges and Emerging Approaches for Lymphoma Management From the First Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma ConferenceAlexey V Danilov, Craig Sauter, Tycel Phillips, et al.
Pageof 14